Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.

ABSTRACT:

Background

Several diabetes mellitus (DM) therapies are associated with worse heart failure (HF) outcomes, yet limited data exist characterizing routine DM management based on HF status.

Hypothesis

DM medications prescribed for patients with HF will differ in meaningful ways from patients without HF, and co-morbidities will impact the choice of medications prescribed.

Methods

Using Medicare fee-for-service claims data, we identified patients with newly treated DM between 2008 and 2011 and used multivariable logistic regression to assess associations between baseline HF status and DM medication use. We used the cumulative incidence function to describe outcomes at 1 year by HF status and DM medication use.

Results

Of 35 603 patients with newly treated DM, 8965 (

SUBMITTER: Cooper LB 

PROVIDER: S-EPMC6490426 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature